Cargando…

Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery

OBJECTIVE: The role of surgery in metastatic colorectal cancer (mCRC) remains controversial. This study was performed to assess the impact of surgery on survival in metastatic colorectal cancer. MATERIALS AND METHODS: Information of mCRC patients diagnosed between January 1, 2004, and December 31, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Fen, Tan, Yi-Nuo, Zhong, Chen-Han, Zhu, Li-Zhen, Fang, Xue-Feng, Li, Jun, Ding, Ke-Feng, Yuan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668074/
https://www.ncbi.nlm.nih.gov/pubmed/29108341
http://dx.doi.org/10.18632/oncotarget.18896
_version_ 1783275610134544384
author Li, Xiao-Fen
Tan, Yi-Nuo
Zhong, Chen-Han
Zhu, Li-Zhen
Fang, Xue-Feng
Li, Jun
Ding, Ke-Feng
Yuan, Ying
author_facet Li, Xiao-Fen
Tan, Yi-Nuo
Zhong, Chen-Han
Zhu, Li-Zhen
Fang, Xue-Feng
Li, Jun
Ding, Ke-Feng
Yuan, Ying
author_sort Li, Xiao-Fen
collection PubMed
description OBJECTIVE: The role of surgery in metastatic colorectal cancer (mCRC) remains controversial. This study was performed to assess the impact of surgery on survival in metastatic colorectal cancer. MATERIALS AND METHODS: Information of mCRC patients diagnosed between January 1, 2004, and December 31, 2013, was retrieved from the Surveillance, Epidemiology, and End Results Program database. Patients were classified in three groups: patients undergoing resection of both primary and distant metastatic tumors (group ‘PMTR’), patients receiving primary tumor resection alone (group ‘PTR’) and patients not undergoing any surgery (group ‘No resection’). Kaplan-Meier method and multivariate Cox proportional hazard regression analysis were applied to estimate disease specific survival time (DSS) and determine prognostic factors. RESULTS: A total of 38,591 mCRC patients were eligible. Overall, median DSS of group ‘PMTR’ was significantly longer compared with group ‘PTR’ and group ‘No resection’ (28.0 vs 21.0 vs 11.0 months, P < 0.001). Stratified analysis observed that primary tumor in left-sided colorectal cancer (LCRC) was a favorable prognostic factor compared with right-sided colorectal cancer (RCRC) (median DSS of LCRC: PMTR, 34 months, PTR, 25 months, No resection, 13 months; median DSS of RCRC: PMTR, 20 months, PTR, 16 months, No resection, 8 months; P < 0.001). Multivariate analysis demonstrated that surgery was an independent prognostic factor for better survival (PMTR, HR = 0.403, 95% CI 0.384–0.423, P < 0.001; PTR, HR = 0.515, 95% CI 0.496–0.534, P < 0.001). Furthermore, in patients undergoing surgery, patients with younger age, female, married status, LCRC and lower CEA level were prone to receiving PMTR. CONCLUSIONS: This analysis demonstrated that surgery was an independent prognostic factor for improved survival in mCRC. Patients with LCRC had better survival than patients with RCRC after surgery.
format Online
Article
Text
id pubmed-5668074
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56680742017-11-04 Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery Li, Xiao-Fen Tan, Yi-Nuo Zhong, Chen-Han Zhu, Li-Zhen Fang, Xue-Feng Li, Jun Ding, Ke-Feng Yuan, Ying Oncotarget Clinical Research Paper OBJECTIVE: The role of surgery in metastatic colorectal cancer (mCRC) remains controversial. This study was performed to assess the impact of surgery on survival in metastatic colorectal cancer. MATERIALS AND METHODS: Information of mCRC patients diagnosed between January 1, 2004, and December 31, 2013, was retrieved from the Surveillance, Epidemiology, and End Results Program database. Patients were classified in three groups: patients undergoing resection of both primary and distant metastatic tumors (group ‘PMTR’), patients receiving primary tumor resection alone (group ‘PTR’) and patients not undergoing any surgery (group ‘No resection’). Kaplan-Meier method and multivariate Cox proportional hazard regression analysis were applied to estimate disease specific survival time (DSS) and determine prognostic factors. RESULTS: A total of 38,591 mCRC patients were eligible. Overall, median DSS of group ‘PMTR’ was significantly longer compared with group ‘PTR’ and group ‘No resection’ (28.0 vs 21.0 vs 11.0 months, P < 0.001). Stratified analysis observed that primary tumor in left-sided colorectal cancer (LCRC) was a favorable prognostic factor compared with right-sided colorectal cancer (RCRC) (median DSS of LCRC: PMTR, 34 months, PTR, 25 months, No resection, 13 months; median DSS of RCRC: PMTR, 20 months, PTR, 16 months, No resection, 8 months; P < 0.001). Multivariate analysis demonstrated that surgery was an independent prognostic factor for better survival (PMTR, HR = 0.403, 95% CI 0.384–0.423, P < 0.001; PTR, HR = 0.515, 95% CI 0.496–0.534, P < 0.001). Furthermore, in patients undergoing surgery, patients with younger age, female, married status, LCRC and lower CEA level were prone to receiving PMTR. CONCLUSIONS: This analysis demonstrated that surgery was an independent prognostic factor for improved survival in mCRC. Patients with LCRC had better survival than patients with RCRC after surgery. Impact Journals LLC 2017-06-30 /pmc/articles/PMC5668074/ /pubmed/29108341 http://dx.doi.org/10.18632/oncotarget.18896 Text en Copyright: © 2017 Li et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Research Paper
Li, Xiao-Fen
Tan, Yi-Nuo
Zhong, Chen-Han
Zhu, Li-Zhen
Fang, Xue-Feng
Li, Jun
Ding, Ke-Feng
Yuan, Ying
Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title_full Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title_fullStr Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title_full_unstemmed Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title_short Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
title_sort left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery
topic Clinical Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668074/
https://www.ncbi.nlm.nih.gov/pubmed/29108341
http://dx.doi.org/10.18632/oncotarget.18896
work_keys_str_mv AT lixiaofen leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT tanyinuo leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT zhongchenhan leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT zhulizhen leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT fangxuefeng leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT lijun leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT dingkefeng leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery
AT yuanying leftsidedprimarytumorisafavorableprognosticfactorformetastaticcolorectalcancerpatientsreceivingsurgery